
With over 40 million Americans on GLP‑1 drugs and 300,000 new users each month, the market is reshaping the entire weight‑loss ecosystem. Brands that adapt by serving the unique needs of medication users can capture a fast‑growing segment, turning a potential threat into a lucrative opportunity while helping consumers manage side effects and sustain health outcomes.
Comments
Want to join the conversation?
Loading comments...